Arthritis News

NEW ORLEANS — Results showed integrating clinical outcomes with laboratory analysis of biological samples may lead to a better understanding of the variable responses to platelet-rich plasma therapy for musculoskeletal conditions.

NEW ORLEANS — Use of an acellular implant made of aragonite may improve outcomes in patients with early arthritis compared with debridement or microfracture, according to results presented at the Biologic Association Annual Summit.

Researchers and CEOs alike presented data recently at a “Shark Tank”-like session with lawmakers on Capitol Hill to discuss, and seek federal funding for, potential therapies for osteoarthritis.

The Secondary Prevention Task Group of the Osteoarthritis Action Alliance released 15 recommendations for the prevention of osteoarthritis after an ACL injury, according to a press release from the National Athletic Trainers Association.

Healio celebrates Mental Health Awareness Month with a focus on physician burnout, an emerging public health crisis among orthopedic physicians and providers.

LAS VEGAS — Use of an implantable shock absorber may be superior to high tibial osteotomy for patients with medial knee osteoarthritis, according to results presented here.

LAS VEGAS — According to presented results, patients who underwent carpometacarpal arthroplasty with metacarpophalangeal fusion had stronger pinch strength compared with patients who underwent carpometacarpal arthroplasty alone.

The Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee of the FDA did not recommend de novo classification for an artificial meniscus implant.

The American Academy of Orthopaedic Surgeons has released two new appropriate use criteria to address clinical scenarios for physicians when managing patients with glenohumeral joint osteoarthritis.

Moximed has announced FDA marketing authorization of its Misha knee system, an implantable shock absorber for patients with knee osteoarthritis, according to a company press release.